Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD)
View Top Employees from Cellestia Biotech| Website | https://www.cellestia.com/ |
| Revenue | $6 million |
| Funding | $25.6 million |
| Employees | 17 (17 on RocketReach) |
| Founded | 2014 |
| Address | Technology Park BaselHochbergerstrasse 60C, Basel, Basel-City 4057, CH |
| Phone | +41 61 633 29 80 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Drug Manufacturing & Research |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Cellestia Biotech employee's phone or email?
Cellestia Biotech Questions
The Cellestia Biotech annual revenue was $6 million in 2024.
17 people are employed at Cellestia Biotech.
Cellestia Biotech is based in Basel, Basel-City.
The NAICS codes for Cellestia Biotech are [54, 54171, 541711, 541, 5417].
The SIC codes for Cellestia Biotech are [28, 283, 2834].
Top Cellestia Biotech Employees
-
41
-
35+
-
-
1
-
-
1
Related Companies
